We characterized the mechanisms by which recombinant (r) tumor necrosis factor (TNF), and 
Hyaluronic acid (HA)' is a ubiquitous polysaccharide, which in vivo is usually a high molecular mass ( 106 to I07 D) component of extracellular matrix and biologic fluids. In these locations HA provides cellular support and regulates cell-cell adhesion, cellular spatial orientation, migration, proliferation, and differentiation ( 1, 2, (3) (4) (5) , and the movement of interstitial fluid and macromolecules (6, 7) . As a result, it is an important contributor to and regulator ofinflammation (8) , wound healing (9, 10) , tissue remodeling (10, 11) , and morphogenesis ( 12) .
HA accumulation is regulated by the balance ofbiosynthesis and degradation. In normals this balance is finely controlled, maintaining appropriate tissue and serum HA levels. However, this balance is altered in many disease states. Increased amounts ofHA have been noted in tissues surrounding malignancies ( 13) , the serum of patients with liver disease ( 14) , the serum and skin ofpatients with scleroderma ( 15, 16) , and the serum and joint fluid of patients with rheumatoid arthritis ( 17, 18) . Exaggerated levels of HA are also seen during compensatory lung growth ( 19) , in the tissues ofanimals with bleomycin-induced pulmonary fibrosis (20) , in the pleural space of patients with mesothelioma (21 ) , and in the lavage fluid of patients with sarcoidosis (22), hypersensitivity pneumonitis (23) , cystic fibrosis (24) , alveolar proteinosis (25) , and asthma (26). However, the mechanisms responsible for these HA abnormalities are poorly understood. This is due, in large part, to an incomplete understanding of the processes regulating HA metabolism in normals and the functioning of these pathways in disease states.
Hyaluronidases (HAases) are endohexosaminidases that initiate the degradation of high molecular weight HA (27, 28) . The lysosomal-type HAases are widely distributed and play a major role in tissue and serum HA turnover (3, (27) (28) (29) (30) (31) . Unlike the testicular HAases, they function best between pH 3 and 4 and are largely inactive at physiologic pH. This has led to the consensus that cellular HA catabolism requires HA-cell binding which is largely receptor-mediated and HA internalization (27, 28, 31) . However, the processes that regulate cellular HAase activity and the effect of alterations in HAase activity on tissue HA accumulation are poorly understood. In addition, since normal human fibroblasts have been reported to lack HAases (31, 32) , the role of fibroblast-derived HAase in tissue repair and remodeling in humans has not been analyzed.
Studies from this and other laboratories have shown that a variety of inflammatory cytokines including IFN-y, tumor necrosis factor (TNF), IL-1, and transforming growth factor-f3 regulate fibroblast HA production (33) (34) (35) . The effects of some of these agents are, at least partially, mediated by cytokine-induced alterations in HA biosynthesis (33) . The degree to which these effects are mediated by alterations in HA degradation, however, has not been elucidated. In addition, even though cytokine-cytokine interactions play a key role in biologic homeostasis and fibroblasts can produce HA with a range of molecular weights and biologic properties ( 18, (36) (37) (38) , the ability of cytokines to interact in regulating the size as well as the quantity of HA produced by stromal tissues has not been adequately investigated.
To further understand the cytokine network regulating HA production, we characterized the effects of recombinant (r) IFN-,y, rTNF, and rIL-1, alone and in combination, on the size and quantity of HA produced by human lung fibroblasts. We also determined if the effects that were seen were due to alterations in HA biosynthesis or HA degradation and characterized the mechanism of the HA degradation that was noted.
Methods

Cytokines and antibodies
Human rIFN-y (1.4 X 10 IU/mg protein) was kindly supplied by Hoffmann-LaRoche, Inc. (Nutley, NJ), rTNF (5 X 107 U/mg protein) was kindly supplied by Dr. H. Michael Sheppard (Genentech, Inc., South San Francisco, CA), and rIL-I-a was a generous gift of Dr. Peter Lomedico (Hoffmann-LaRoche, Inc.). These cytokines were added directly to fibroblast cultures after dilution. A monoclonal antibody against rIFN-y and a monoclonal antibody against rTNF were obtained from Genentech, Inc. Rabbit antiserum against rIL-1-a was obtained from Smith, Kline & French, Inc. (King of Prussia, PA).
Fibroblast cell lines
Strain CCL-202 normal adult human lung fibroblasts were obtained from the American Type Culture Collection (Rockville, MD) and passed less than five times in our laboratory. They were grown to confluence in Dulbecco's modified Eagle's medium supplemented with nonessential amino acids (Gibco BRL, Grand Island, NY), penicillin, streptomycin (complete medium), and 10% heat-inactivated FBS (Gibco BRL).
Assessment offibroblast glycosaminoglycan (GAG) biosynthesis
The GAG production of unstimulated and cytokine-stimulated confluent fibroblasts incubated under serum-free conditions was evaluated using isotopic and chemical approaches. The isotopic technique assessed fibroblast incorporation of [6-H3]D-glucosamine hydrochloride into pronase-resistant, cetylpyridinium chloride (CPC)-precipitable material. In chosen experiments cell number was simultaneously assessed via hemacytometer counting. The chemical assessment employed pronase and nuclease treatment, cellulose acetate electrophoresis, and '251I-cytochrome c staining. Our use of these techniques has been described previously (33) .
Characterization ofGAGs
Isotopic. The type and the size ofGAGs produced by unstimulated and cytokine-stimulated fibroblasts were assessed as described previously (33) . In brief, GAGs were isolated by CPC precipitation and sized using Biogel P-10(Bio-Rad Laboratories, Richmond, CA) and Sepharose CL-2B (Pharmacia LKB Biotechnology Inc., Piscataway NJ) columns. The void volume of the CL-2B column was established using polymerized calfthymus DNA (Sigma Chemical Co., St. Louis, MO). The GAGs were then incubated with protease-free, HA-specific (39) hyaluronidase (Streptomyces hyaluronyliticus) (Calbiochem-Behring Corp., La Jolla, CA) (20 U in 0.02 M acetate buffer [pH 5.01 for 16 h at 560C) and reeluted from the Biogel P-l0 column. Since the undigested GAGs appear in the void volume and the digestate appears in the inclusion volume of the column, comparison of the patterns of 3H elution before and after digestion allowed determination of the percentage of label incorporated into HA.
ChemicaL The GAGs produced by untreated and cytokine-treated fibroblasts and known GAG controls were applied to individual lanes of cellulose acetate strips, electrophoresed, and stained with '25I-cytochrome c as described (33) .
Assessment offibroblast hyaluronate synthetase activity
The cell-free HA synthesizing capacity of untreated and cytokinetreated fibroblasts was assessed by characterizing the ability of fibroblast sonicates to incorporate UDP-['4C]glucuronic acid into CPCprecipitable HA. This was done using the modifications of the techniques of Eppig and Ward-Bailey (40) and Appel et al. (41) we described previously (33) .
Characterization offibroblast HA degradation
We determined whether unstimulated and cytokine-stimulated fibroblasts differed in their ability to degrade [3H ]HA.
Preparation of [3H]HA. Confluent fibroblasts in microtiter wells were incubated in complete medium supplemented with 20-30% FBS, and 0.02 ml [3H]glucosamine ( 150-200 uCi/ ml) for 72 h. Pronase digestion and CPC precipitation were used to isolate the HA that was produced. The precipitates were collected by centrifugation, resolubilized in 2 M MgCl2, reprecipitated with alcohol, collected after centrifugation (8,000 g, 10 min), resuspended in distilled H20 and applied to and eluted from a Sepharose CL-2B column using 0.1 M ammonium acetate pH 7. The radiolabeled material that eluted in the void volume of the column was precipitated with alcohol, collected after centrifugation, and resuspended in complete medium. This high molecular weight material was > 98% HA when assessed using the techniques described above and had a specific activity between 0. 19 preliminary experiments demonstrated that it allowed for maximal HA degradation. The solutions were then applied to and eluted from Sepharose CL-2B or CL-6B columns. These incubations were performed in the presence of 0.5 to 6 mM saccharolactone (Sigma). In specific experiments, incubations were performed after boiling the fibroblast supernatant and/or lysate.
Sodium borotritiide analysis. To determine whether the HA degrading activity in the supernatants and/or lysates was the result of an endohexosaminidase or an endoglucuronidase, sodium borotritiide analysis was performed. Before digestion, 1.4 mg of umbilical cord HA (Sigma) was dissolved in 1 ml ofH20 and 5 ml ammonium hydroxide was added. The solution was immediately transferred into a tube containing 1.8 mg sodium borohydride and incubated on ice for 45 min. Glacial acetic acid was carefully added drop-wise, followed by Dowex 50 H+. The Dowex 50 H+ was removed by centrifugation, methanol was added to the supernatant, and the solution evaporated. The evaporation in the presence of acidic methanol was repeated twice. The HA was then redissolved in water and precipitated with 5 vol of sodium acetate-saturated ethanol. A precipitate was allowed to form in the cold overnight and then removed by centrifugation and lyophylized. Recovery was 99-100%. The reduced HA was redissolved in 2 M NaCl and divided into two aliquots. The first aliquot contained 0.2 ml ofreduced HA and received 1 ml of acidified fibroblast supernatant. The second tube contained a similar volume of reduced HA and received 1 ml of acidic buffer only. After an overnight incubation at 37°C, concentrated NaOH was added until the pH was greater than or equal to 8, and 5 mCi ofNaB3H4 was added. The samples were placed on ice for 30 min, acidified with glacial acetic acid and Dowex 50 H+, evaporated in the presence of acidic methanol, and precipitated with 5 vol of sodium acetate-saturated ethanol as described above. The newly radiolabeled digested HA sample was then applied to and eluted from a Sepharose CL-6B column. The enzymatically digested portion eluting in the included volume ofthe column was pooled, treated with testicular HAase (Sigma, 700 U, 16 h, 37°C, pH 5.0) and analyzed on a Biogel P-10 column. The testicular HAase-sensitive material appeared in the included volume ofthis column. It was pooled, hydrolyzed in 1 N HC1 (5 h, 100°C), diluted with water and applied to a Dowex 50 H+ column (bed vol 0.5 ml) and then eluted sequentially with H20 followed by 0.5 and then 2.0 M HC. Authentic radiolabeled glucosaminitol was made by reducing glucosamine with borotritiide in a similar fashion. It was also applied to and eluted from the Dowex 50 H+ column. The runthrough obtained with our test and control samples and the radiolabeled glucosaminitol were then diluted with water and applied to a Dowex 1 x 10 column (bed vol 0.5 ml) which was eluted with increasing concentrations of formic acid up to 0.8 M, followed by 2.5 N HC1. 16 h with fibroblast supernatants and/or lysates at pH 3.7 as described above. The products ofdigestion were then eluted serially from Sepharose CL-2B, Sepharose CL-6B, and Biogel P-10 columns. The Sepharose CL-6B column had a 1 cm x 120 cm bed vol and had been previously calibrated using high molecular weight HA to determine its void volume (Vo), [3HIglucosamine to determine its salt region (VT), and 30 kD and 10 kD [3HIheparan sulfate (gifts of Dr. Renato Iozzo, Philadelphia, PA) to calibrate its included volume. The end products of digestion of fibroblast HAase were compared to those produced by testicular HAase incubated with HA at its pH optimum. To determine whether the large saccharide end products of digestion produced by the fibroblast supernatants and lysates were the result of a limitation in enzyme quantity, fractions eluting in the included volume ofthe Sepharose CL-6B column were pooled, redigested with fibroblast-derived HAase, and reanalyzed using these columns. To determine ifinhibitors of HAase were present in the fibroblast lysates or supernatants, experiments were performed in which the effect of testicular HAase on [3HIHA degradation was evaluated in the presence and absence of fibroblast lysates (prepared in TF buffer at pH 7.2). The size of the digestates obtained under these control and test conditions were analyzed as noted above.
Sizing ofendproducts ofdigestion. [3H]HA was incubated for
Characterization ofHA-fibroblast binding Two techniques were used to characterize the specificity of fibroblast-HA binding. In some experiments untreated and cytokine-treated fibroblasts were incubated with [3H]HA in the presence and absence of 300 mg/ml of unlabeled HA, chrondroitin-4-6 sulfate (Sigma), dermatan sulfate (Sigma), or heparin (Sigma), and the ability of these GAG moieties to compete with [3H]HA for cell binding was assessed.
In other experiments fibroblasts were incubated with [3H]HA for 4 h. They were then vigorously washed and incubated for 1-2 h in the presence and absence of unlabeled HA, chrondroitin-4-6 sulfate, dermatan sulfate, or heparin (300 mg/ml for each). The ability of these moieties to displace bound HA was then compared. mRNA isolation and analysis Total cellular RNA was extracted from fibroblast monolayers, sizefractionated using agarose-formaldehyde gel electrophoresis, transferred to nylon membranes, and hybridized with 32P-labeled cDNA probes, as described previously (42) . Clone HCAM short, encoding a portion of CD44, was a gift of Dr. Eugene Butcher (Stanford University, Palo Alto, CA) (43) . Clone pCSF-309, a full length cDNA encoding human IL-6, was a gift of Dr. Steven Clark (Genetics Institute, Cambridge, MA). Plasmids containing cDNA encoding the 28 S ribosomal gene were a gift of Dr. S. Adams (University of Pennsylvania, Philadelphia, PA). After hybridization the membranes were washed under high stringency conditions and subjected to autoradiography.
Results
Effects ofcytokines on GAG accumulation. Unstimulated fibroblasts produced modest amounts ofGAG. As noted previously (33) , rIFN-y and rTNF individually caused a modest increase in fibroblast GAG accumulation and rIFN-y plus rTNF interacted in a synergistic fashion to further increase GAG accumulation (Table I ; Figure 1 ). These stimulatory effects were seen after as little as 24 h and were more prominent after 72 h of (Table I) or on the production of sulfated GAGs (Fig. 2) . Recombinant IL-la also stimulated fibroblast GAG production. This effect was dose dependent with peak stimulation noted with 2.5 ng/ml ofthis cytokine (the highest dose tested) ( Fig. 1) . At this concentration fibroblasts incubated with rIL-1-a incorporated 190% as much [3H]glucosamine into GAG as controls (P < 0.001 vs. control, paired t test). Recombinant IL-1-1 had similar stimulatory effects (data not shown). In contrast to the synergistic interaction of rIFN-y and rTNF, high concentrations of rIL-1 and rTNF interacted, at most, in an additive fashion in stimulating fibroblast GAG production ( Figs. 1 and 2 ). This additive interaction was dose dependent for both cytokines (Fig. 1 ) and could not be attributed to alterations in cell number (data not shown). The stimulatory effects ofrIL-1 and rTNF, alone and in combination, were noted with isotopic and chemical assessments ofGAG accumulation ( Figs. 1 and 2 ) and thus could not be explained by changes in
[3H ]glucosamine pool size. In addition, these stimulatory effects appeared to be at least partially specific for HA since > 95% of the 125I-cytochrome c-binding material produced by these cells was HA (Fig. 2) , > 90% of the [3H]glucosaminelabeled material produced by these cells was sensitive to digestion with streptomyces hyaluronidase (data not shown), and these cytokines were unable to significantly stimulate I'S incorporation into sulphur containing moieties (Table I) .
Recombinant cytokine regulation offibroblast hyaluronate synthetase activity. To determine whether cytokine-induced alterations in HA accumulation could be adequately explained by cytokine-induced alterations in HA biosynthesis, we measured the hyaluronate synthetase activity of unstimulated and cytokine-stimulated fibroblasts. Unstimulated fibroblasts manifest modest levels of hyaluronate synthetase activity. In keeping with their effects on HA accumulation, rIFN-y, rTNF, and rIL-1 individually caused modest increases, and rTNF and rIFN-'y in combination synergistically augmented fibroblast hyaluronate synthetase activity (Table II) . Even though rIL-1 and rTNF, in combination, had an additive or lesser effect on HA accumulation, this cytokine combination synergistically augmented hyaluronate synthetase activity. In fact, the levels ofhyaluronate synthetase activity in cells stimulated with rIL-l plus rTNF were consistently greater than the levels seen in cells incubated with rIFN-'y plus rTNF (Table II) . Thus, cytokineinduced alterations in hyaluronate synthetase activity do not fully explain the effects of these regulatory agents on fibroblast HA accumulation.
Effect of recombinant cytokines on the size of the HA in fibroblast cultures. We incubated unstimulated and cytokinestimulated fibroblasts with [3H]glucosamine, isolated the HA that was produced, and obtained an index of its size using Sepharose CL-2B chromatography. As seen in Table III, a (Table III ). These studies demonstrate that rIFN-T plus rTNF interact in a synergistic fashion to stimulate the accumulation of high molecular weight HA. In contrast, rTNF interacts with rIL-1 to cause an additive increase in HA accumulation with a disproportionate amount of this HA having a low molecular weight.
Recombinant cytokine regulation ofHA degradation by intact fibroblasts. The finding that cytokine-induced alterations in fibroblast HA accumulation could not be fully accounted for by cytokine-induced alterations in HA biosynthesis prompted us to determine whether cytokine-induced alterations in HA degradation were involved in this process. In these studies fibroblast HA-degrading capacity was characterized by comparing the patterns ofelution from a Sepharose CL-2B column ofhigh molecular weight log TNF concentration (ng/ml) a modest increase in HA degradation (Table III) (Fig. 3) . Supernatant HA degrading activity was maximal at a pH of 3.7-4.0 (Fig. 4) (Table III) . Recombinant IFN-'y did not alter, while rTNF and rIL-1 caused modest increases in HAase activity. Recombinant IFN-y plus rTNF and rIL-l plus rTNF also caused modest increases in HAase activity (Table III) .
However, the former cytokine combination inhibited while the latter combination augmented HA degradation. Thus, although detergent lysates of human lung fibroblasts contain HAase activity, the levels ofthis activity did not correlate fully with the HA degrading capacity of unstimulated and cytokine stimulated fibroblasts.
Cytokine regulation ofHA-fibroblast binding. The pH profile of fibroblast HAase suggests that it is a lysosomal enzyme whose function requires HA binding and internalization (3, 27, 28) . Since the HA degrading activity ofwhole cells did not correlate with that of cell lysates, we speculated that cellular HA degradation was regulated at the level ofcellular HA binding. To test this hypothesis we compared the ability ofunstimulated and cytokine-stimulated fibroblasts to specifically bind HA. Unstimulated fibroblasts bound modest amounts of HA.
Recombinant IFN-'y, rTNF, and rIL-l caused modest increases in this binding. Recombinant IFN-7 plus rTNF, a cytokine combination that inhibited cellular HA degradation, caused a significant decrease in HA binding (Table III) . In contrast, rIL-1 plus rTNF, a cytokine combination that increased cellular HA degradation, increased HA binding (Fig.  3) . These cytokine-induced alterations in HA binding were seen after as little as 24 h of cytokine-fibroblast incubation. In addition, they could not be attributed to effects of endogenously produced HA since binding was not altered by preincubation with streptomyces HAase (data not shown). In all cases, the receptor(s) involved in this binding was at least partially specific for HA since concentrations of chrondroitin sulfate, dermatan sulfate and heparin as high as 300 mg/ml competed weakly, ifat all, with HA for cellular binding (data not shown) .
These studies demonstrate a correlation between cytokine-induced alterations in the HA degrading activity and cellular HA binding.
Cytokine regulation of CD44 mRNA. Studies were undertaken to determine if cytokine-induced alterations in HA-fibroblast binding were associated with comparable alterations in the levels of mRNA encoding CD44, a major cellular HA receptor (43, 44) . Unstimulated normal lung fibroblasts expressed three mRNA isoforms encoding CD44. Recombinant IL-l and rTNF, individually, augmented all three CD44 isoforms with rIL-I being more potent (Fig. 6) . Incubating fibroblasts with rIL-1 and rTNF in combination caused a further increase in CD44 mRNA accumulation (Fig. 6 ). This effect was seen after as little as 4 h of fibroblast-cytokine incubation (data not shown). In contrast, rIFN-,y did not significantly alter, or decreased the levels of CD44 mRNA in unstimulated and rTNF stimulated cells (Fig. 6 ). When these blots were probed for IL-6 mRNA a distinctly different pattern of hybridization was noted (Fig. 6) 
